Nivolumab vs Sumatriptan
Nivolumab vs Sumatriptan: Overview
This comparison examines the pharmacological differences between Nivolumab and Sumatriptan.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Sumatriptan: Selective 5-HT1B/1D receptor agonist.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Sumatriptan — 2.5 hours.
Chemical Properties
Molecular Formula: Sumatriptan — C14H21N3O2S.
Molecular Weight: Sumatriptan — 295.4020 g/mol.
Type: Nivolumab — Antibody; Sumatriptan — Small molecule.